Skip to main content
OpenTrials
Completed

NCT Number: NCT04300400

Treatment of the Overactive Bladder Syndrome: A Delphi Study

Idiopathic overactive bladder syndrome (iOAB) is a prevalent condition in urological practice. The variability in management between specialists and between centers remains high. Even guidelines are not always clear on the treatment management of drug therapy resistant OAB. Standardization in OAB treatment is needed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Overactive Bladder Syndrome

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Ghent

Ghent, East-Flanders, 9000, Belgium

About this study

Guidelines on the overactive bladder syndrome (European Association of Urology, American Urology Association and International Consultation on Incontinence) are comparable but remain vague mainly on the level between conservative and major surgery. They do not specify combinations of medications and do not distinguish between intradetrusor botulinum toxin injections (BTX) and sacral neuromodulation (SNM) because of lack of evidence.

To reduce the variability in the treatment management of OAB, standardization is needed.

By use of a Delphi technique, the current perception of Belgian urologists towards the most appropriate treatment approach for idiopathic OAB (iOAB) was explored.

Based on these results a practical treatment algorithm for its use in daily clinical practice could be developed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Profession: MD, Urologist
  • Member of the working group of Functional Urology

Exclusion criteria

  • Retirement
  • Non-operative as an urologist.

Treatment and study plan

Delphi Questionnaire

Other

Statements on OAB topics, rated along their level of appropriateness on a scale from 1 to 9. Multiple rounds are organised to reach consensus on a topic.

Primary outcomes

  1. Degree of consensus on the level of appropriateness

    Time frame: 8 months

    No consensus, trend towards consensus or consensus

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Collaborators

  • Astellas Pharma Inc
  • Medtronic

Registry information

Official study title

Development of a Flowchart Reflecting the Current Attitude and Approach Towards the Idiopathic Overactive Bladder Treatment in Belgium: A Delphi Study

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Mar 9, 2020
Registry last updated
Jan 19, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.